Historical shareholding details of
TD Asset Management Inc
holdings in MoonLake Immunotherapeutics - Ordinary Shares - Class A (MLTX)
Monthly changes of
TD Asset Management Inc
shareholding in MoonLake Immunotherapeutics - Ordinary Shares - Class A
over the previous
months
|
Month
|
Name |
Total no. shares held |
Percent Holding |
|
Mar 31, 2025
|
Td Asset Management Inc
|
0
|
0.00%
|
|
|
|
Feb 28, 2025
|
Td Asset Management Inc
|
0
|
0.00%
|
|
|
|
Jan 31, 2025
|
Td Asset Management Inc
|
0
|
0.00%
|
|
|
|
Dec 31, 2024
|
Td Asset Management Inc
|
261,634
|
0.41%
|
|
Dec 31, 2024
|
Td Asset Management Inc
|
0
|
0.00%
|
|
|
|
Nov 30, 2024
|
Td Asset Management Inc
|
0
|
0.00%
|
|
|
|
Oct 31, 2024
|
Td Asset Management Inc
|
0
|
0.00%
|
|
|
|
Sep 30, 2024
|
Td Asset Management Inc
|
215,834
|
0.34%
|
|
Sep 30, 2024
|
Td Asset Management Inc
|
0
|
0.00%
|
|
|
|
Aug 31, 2024
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Jul 31, 2024
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Jun 30, 2024
|
Td Asset Management Inc
|
209,234
|
0.33%
|
|
Jun 30, 2024
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
May 31, 2024
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Apr 30, 2024
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Mar 31, 2024
|
Td Asset Management Inc
|
204,094
|
0.32%
|
|
Mar 31, 2024
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Feb 29, 2024
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Jan 31, 2024
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Dec 31, 2023
|
Td Asset Management Inc
|
209,142
|
0.33%
|
|
Dec 31, 2023
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Nov 30, 2023
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Oct 31, 2023
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Sep 30, 2023
|
Td Asset Management Inc
|
200,390
|
0.33%
|
|
Sep 30, 2023
|
Td Asset Management Inc
|
12,333
|
0.02%
|
|
|
|
Jun 30, 2023
|
Td Asset Management Inc
|
99,640
|
0.19%
|
|
|
|
Mar 31, 2023
|
Td Asset Management Inc
|
67,312
|
0.13%
|
View all ownership details of MoonLake Immunotherapeutics - Ordinary Shares - Class A